Αρχειοθήκη ιστολογίου

Τρίτη 20 Ιουνίου 2017

Triplet Combo Active in Lenalidomide/Refractory Multiple Myeloma

Combining bendamustine, pomalidomide, and dexamethasone achieved a promising overall response rate in patients with heavily pretreated lenalidomide refractory multiple myeloma, according to the results of a phase I/II trial. (Source: CancerNetwork)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2tM8EW6
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader